Literature DB >> 11036002

A neutrophil-derived anti-infective molecule: bactericidal/permeability-increasing protein.

O Levy1.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 11036002      PMCID： PMC101582          DOI： 10.1128/AAC.44.11.2925-2931.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  62 in total

1.  Separation of sublethal and lethal effects of polymorphonuclear leukocytes on Escherichia coli.

Authors:  B A Mannion; J Weiss; P Elsbach
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

2.  Separation of sublethal and lethal effects of the bactericidal/permeability increasing protein on Escherichia coli.

Authors:  B A Mannion; J Weiss; P Elsbach
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

3.  Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group.

Authors:  M Levin; P A Quint; B Goldstein; P Barton; J S Bradley; S D Shemie; T Yeh; S S Kim; D P Cafaro; P J Scannon; B P Giroir
Journal:  Lancet       Date:  2000-09-16       Impact factor: 79.321

4.  Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability increasing protein to target bacteria. Implications and use as a means of purification.

Authors:  B A Mannion; E S Kalatzis; J Weiss; P Elsbach
Journal:  J Immunol       Date:  1989-04-15       Impact factor: 5.422

5.  Oxygen-independent intracellular and oxygen-dependent extracellular killing of Escherichia coli S15 by human polymorphonuclear leukocytes.

Authors:  J Weiss; L Kao; M Victor; P Elsbach
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

6.  The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope.

Authors:  J Weiss; K Muello; M Victor; P Elsbach
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

7.  Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.

Authors:  J Weiss; P Elsbach; C Shu; J Castillo; L Grinna; A Horwitz; G Theofan
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

8.  Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity.

Authors:  M N Marra; C G Wilde; J E Griffith; J L Snable; R W Scott
Journal:  J Immunol       Date:  1990-01-15       Impact factor: 5.422

9.  Cloning of the cDNA of a human neutrophil bactericidal protein. Structural and functional correlations.

Authors:  P W Gray; G Flaggs; S R Leong; R J Gumina; J Weiss; C E Ooi; P Elsbach
Journal:  J Biol Chem       Date:  1989-06-05       Impact factor: 5.157

10.  Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease.

Authors:  K R Cooke; G R Hill; J M Crawford; D Bungard; Y S Brinson; J Delmonte; J L Ferrara
Journal:  J Clin Invest       Date:  1998-11-15       Impact factor: 14.808
View more
  22 in total

Review 1.  Antimicrobial aspects of inflammatory resolution in the mucosa: a role for proresolving mediators.

Authors:  Eric L Campbell; Charles N Serhan; Sean P Colgan
Journal:  J Immunol       Date:  2011-10-01       Impact factor: 5.422

Review 2.  Mammalian antibiotic peptides.

Authors:  P Síma; I Trebichavský; K Sigler
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

3.  Endotoxin{middle dot}albumin complexes transfer endotoxin monomers to MD-2 resulting in activation of TLR4.

Authors:  Gregory A Esparza; Athmane Teghanemt; DeSheng Zhang; Theresa L Gioannini; Jerrold P Weiss
Journal:  Innate Immun       Date:  2011-10-12       Impact factor: 2.680

4.  Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia.

Authors:  Geraldine Canny; Ofer Levy; Glenn T Furuta; Sailaja Narravula-Alipati; Richard B Sisson; Charles N Serhan; Sean P Colgan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

5.  rBPI21 (Opebacan) Promotes Rapid Trilineage Hematopoietic Recovery in a Murine Model of High-Dose Total Body Irradiation.

Authors:  Kenneth J Janec; Huaiping Yuan; James E Norton; Rowan H Kelner; Christian K Hirt; Rebecca A Betensky; Eva C Guinan
Journal:  Am J Hematol       Date:  2018-05-11       Impact factor: 10.047

6.  Endotoxin-directed innate immunity in tracheal aspirates of mechanically ventilated human neonates.

Authors:  Katheryn E Nathe; Richard Parad; Linda J Van Marter; Cara A Lund; Eugénie E Suter; Sonia Hernandez-diaz; Elizabeth B G Boush; Eva Ikonomu; Leighanne Gallington; Jo Ann Morey; Alenka M Zeman; Meaghan Mcnamara; Ofer Levy
Journal:  Pediatr Res       Date:  2009-08       Impact factor: 3.756

7.  The Vibrio cholerae ToxR-regulated porin OmpU confers resistance to antimicrobial peptides.

Authors:  Jyoti Mathur; Matthew K Waldor
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

8.  Endosomolytic reducible polymeric electrolytes for cytosolic protein delivery.

Authors:  Li Tian; Han Chang Kang; You Han Bae
Journal:  Biomacromolecules       Date:  2013-07-11       Impact factor: 6.988

9.  Decreased pattern recognition receptor signaling, interferon-signature, and bactericidal/permeability-increasing protein gene expression in cord blood of term low birth weight human newborns.

Authors:  Vikas Vikram Singh; Sudhir Kumar Chauhan; Richa Rai; Ashok Kumar; Shiva M Singh; Geeta Rai
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

Review 10.  Killing three birds with one BPI: Bactericidal, opsonic, and anti-inflammatory functions.

Authors:  Jomkuan Theprungsirikul; Sladjana Skopelja-Gardner; William F C Rigby
Journal:  J Transl Autoimmun       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.